Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
Cedars-Sinai Medical Center
PubMed
38261310
PubMed Central
PMC11020428
DOI
10.2215/cjn.0000000000000398
PII: 01277230-202404000-00007
Knihovny.cz E-zdroje
- MeSH
- biopsie MeSH
- dítě MeSH
- dospělí MeSH
- hodnoty glomerulární filtrace MeSH
- IgA nefropatie * komplikace farmakoterapie patologie MeSH
- IgA vaskulitida * komplikace farmakoterapie patologie MeSH
- ledviny patologie MeSH
- lidé MeSH
- mladiství MeSH
- nefritida * komplikace MeSH
- proteinurie etiologie MeSH
- retrospektivní studie MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Nephritis is a common manifestation of IgA vasculitis and is morphologically indistinguishable from IgA nephropathy. While MEST-C scores are predictive of kidney outcomes in IgA nephropathy, their value in IgA vasculitis nephritis has not been investigated in large multiethnic cohorts. METHODS: Biopsies from 262 children and 99 adults with IgA vasculitis nephritis ( N =361) from 23 centers in North America, Europe, and Asia were independently scored by three pathologists. MEST-C scores were assessed for correlation with eGFR/proteinuria at biopsy. Because most patients ( N =309, 86%) received immunosuppression, risk factors for outcomes were evaluated in this group using latent class mixed models to identify classes of eGFR trajectories over a median follow-up of 2.7 years (interquartile range, 1.2-5.1). Clinical and histologic parameters associated with each class were determined using logistic regression. RESULTS: M, E, T, and C scores were correlated with either eGFR or proteinuria at biopsy. Two classes were identified by latent class mixed model, one with initial improvement in eGFR followed by a late decline (class 1, N =91) and another with stable eGFR (class 2, N =218). Class 1 was associated with a higher risk of an established kidney outcome (time to ≥30% decline in eGFR or kidney failure; hazard ratio, 5.84; 95% confidence interval, 2.37 to 14.4). Among MEST-C scores, only E1 was associated with class 1 by multivariable analysis. Other factors associated with class 1 were age 18 years and younger, male sex, lower eGFR at biopsy, and extrarenal noncutaneous disease. Fibrous crescents without active changes were associated with class 2. CONCLUSIONS: Kidney outcome in patients with biopsied IgA vasculitis nephritis treated with immunosuppression was determined by clinical risk factors and endocapillary hypercellularity (E1) and fibrous crescents, which are features that are not part of the International Study of Diseases of Children classification.
Bambino Gesù Children's Hospital IRCCS Rome Italy
BC Renal Vancouver British Columbia Canada
Centre for Research on Inflammation Bichat Hospital Inserm and Université Paris Cité Paris France
Clinical Research Center Takatsuki General Hospital Wakayam Medical University Takatsuki City Japan
Comitato Tecnico Scientifico per la Ricerca e Innovaziione A O Santobono Pausilipon Naples Italy
Department of Cellular Pathology Oxford University Hospitals NHS FT Oxford United Kingdom
Department of Children and Adolescents Oulu University Hospital Oulu Finland
Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota
Department of Medicine and Surgery IRCCS San Gerardo University Milan Bicocca Monza Italy
Department of Nephrology 1st Faculty of Medicine General University Hospital Prague Czech Republic
Department of Nephrology and Hypertension Jikei University School of Medicine Tokyo Japan
Department of Nephrology Juntendo University Faculty of Medicine Tokyo Japan
Department of Pathology and Laboratory Medicine Cedars Sinai Medical Center Los Angeles California
Department of Pathology and Medical Biology University of Groningen Groningen The Netherlands
Department of Pathology AP HP Hôpital Bichat Université Paris Cité Paris France
Department of Pathology Johns Hopkins University School of Medicine Baltimore Maryland
Department of Pathology Mass General Brigham Salem Hospital Salem Massachusetts
Department of Pathology The Jikei University School of Medicine Tokyo Japan
Department of Pathology University of Kentucky Medical Center Lexington Kentucky
Department of Pathology University of Toronto Toronto Ontario Canada
Department of Pathology University of Utah Salt Lake City Utah
Department of Pathology Washington University in Saint Louis St Louis Missouri
Department of Pediatrics Peking University 1st Hospital Beijing China
Department of Pediatrics University of Tennessee Health Sciences Center Memphis Tennessee
Department of Pediatrics Wakayama Medical University Wakayama Japan
Division of Dialysis Department of Nephrology University of Miyazaki Hospital Miyazaki Japan
Division of Nephrology and Hypertension Mayo Clinic Rochester Minnesota
Division of Nephrology Bambino Gesù Children's Hospital IRCCS Rome Italy
Division of Nephrology University of British Columbia Vancouver British Columbia Canada
Division of Pediatric Nephrology Department of Pediatrics University of Utah Salt Lake City Utah
Division of Pediatric Nephrology University of British Columbia Vancouver British Columbia Canada
Fondazione Ricerca Molinette Regina Margherita Hospital Turin Italy
Imperial College London London United Kingdom
INSERM U1149 and Université Paris Cité Paris France
Institute of Pathology University Hospital of Cologne Cologne Germany
Kidney Unit National Hospital Organization Fukuokahigashi Medical Center Fukuoka Japan
Laboratory of Electron Microscopy Pathological Center Peking University 1st Hospital Beijing China
Nephrology and Dialysis Unit AOU G Martino University of Messina Messina Italy
Nephrology and Dialysis Unit Meyer Children's Hospital Florence Italy
Nephrology Bichat Hospital AP HP Paris France
Nephrology Unit Saint Louis Hospital Paris France
Pathology Department Bambino Gesù Children's Hospital Rome Italy
Pathology Unit Città della Salute e della Scienza di Torino University Hospital Turin Italy
Pathology University Oulu and Oulu University Hospital Oulu Finland
Pediatrics Clinical Trials Office University of Utah Salt Lake City Utah
doi: 10.2215/CJN.0000000000000444 PubMed
Zobrazit více v PubMed
Davin JC, Coppo R. Henoch-Schonlein purpura nephritis in children. Nat Rev Nephrol. 2014;10(10):563–573. doi:10.1038/nrneph.2014.126 PubMed DOI
Hastings MC Rizk DV Kiryluk K, et al. . IgA vasculitis with nephritis: update of pathogenesis with clinical implications. Pediatr Nephrol. 2022;37(4):719–733. doi:10.1007/s00467-021-04950-y PubMed DOI PMC
Allen AC, Willis FR, Beattie TJ, Feehally J. Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant. 1998;13(4):930–934. doi:10.1093/ndt/13.4.930 PubMed DOI
Saulsbury FT. Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore). 1999;78(6):395–409. doi:10.1097/00005792-199911000-00005 PubMed DOI
Tancrede-Bohin E, Ochonisky S, Vignon-Pennamen MD, Flageul B, Morel P, Rybojad M. Schonlein-Henoch purpura in adult patients. Predictive factors for IgA glomerulonephritis in a retrospective study of 57 cases. Arch Dermatol. 1997;133(4):438–442. doi:10.1001/archderm.133.4.438 PubMed DOI
Haas M. IgA nephropathy and IgA vasculitis (Henoch-Schonlein purpura) nephritis. In: Jenette JC, Olsen JL, Silva FG, D’Agati VD, eds. Hepinstall’s Pathology of the Kidney, 7th ed. Wolters-Kluwer; 2015:463–523.
Heineke MH, Ballering AV, Jamin A, Ben Mkaddem S, Monteiro RC, Van Egmond M. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schonlein purpura). Autoimmun Rev. 2017;16(12):1246–1253. doi:10.1016/j.autrev.2017.10.009 PubMed DOI
Koskela M Ylinen E Ukonmaanaho EM, et al. . The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schonlein purpura nephritis. Pediatr Nephrol. 2017;32(7):1201–1209. doi:10.1007/s00467-017-3608-5 PubMed DOI
Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F. Clinical outcome of Schonlein-Henoch purpura nephritis in children. Pediatr Nephrol. 1999;13(9):816–823. doi:10.1007/s004670050707 PubMed DOI
Edstrom Halling S, Soderberg MP, Berg UB. Predictors of outcome in Henoch-Schonlein nephritis. Pediatr Nephrol. 2010;25(6):1101–1108. doi:10.1007/s00467-010-1444-y PubMed DOI
Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schonlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002;13(5):1271–1278. doi:10.1097/01.ASN.0000013883.99976.22 PubMed DOI
Cattran DC Coppo R Cook HT, et al. .; Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534–545. doi:10.1038/ki.2009.243 PubMed DOI
Coppo R Troyanov S Bellur S, et al. . Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int. 2014;86(4):828–836. doi:10.1038/ki.2014.63 PubMed DOI PMC
Haas M, Rastaldi MP, Fervenza FC. Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification. Kidney Int. 2014;85(4):779–793. doi:10.1038/ki.2013.375 PubMed DOI
Roberts ISD Cook HT Troyanov S, et al. .; Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76(5):546–556. doi:10.1038/ki.2009.168 PubMed DOI
Barbour SJ Espino-Hernandez G Reich HN, et al. . The MEST score provides earlier risk prediction in lgA nephropathy. Kidney Int. 2016;89(1):167–175. doi:10.1038/ki.2015.322 PubMed DOI
Barbour SJ Coppo R Zhang H, et al. . Evaluating a new international risk-prediction Tool in IgA nephropathy. JAMA Intern Med. 2019;179(7):942–952. doi:10.1001/jamainternmed.2019.0600 PubMed DOI PMC
Zhang Y Guo L Wang Z, et al. . External validation of international risk-prediction models of IgA nephropathy in an asian-Caucasian cohort. Kidney Int Rep. 2020;5(10):1753–1763. doi:10.1016/j.ekir.2020.07.036 PubMed DOI PMC
Kidney Disease Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical Practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4S):S1–S276. doi:10.1016/j.kint.2021.05.021 PubMed DOI
Kim CH Lim BJ Bae YS, et al. . Using the Oxford classification of IgA nephropathy to predict long-term outcomes of Henoch-Schonlein purpura nephritis in adults. Mod Pathol. 2014;27(7):972–982. doi:10.1038/modpathol.2013.222 PubMed DOI
Huang X Ma L Ren P, et al. . Updated Oxford classification and the international study of kidney disease in children classification: application in predicting outcome of Henoch-Schonlein purpura nephritis. Diagn Pathol. 2019;14(1):40. doi:10.1186/s13000-019-0818-0 PubMed DOI PMC
Cakici EK Gur G Yazilitas F, et al. . A retrospective analysis of children with Henoch-Schonlein purpura and re-evaluation of renal pathologies using Oxford classification. Clin Exp Nephrol. 2019;23(7):939–947. doi:10.1007/s10157-019-01726-5 PubMed DOI
Jimenez A, Chen A, Lin JJ, South AM. Does MEST-C score predict outcomes in pediatric Henoch-Schonlein purpura nephritis?. Pediatr Nephrol. 2019;34(12):2583–2589. doi:10.1007/s00467-019-04327-2 PubMed DOI PMC
Xu K Zhang L Ding J, et al. . Value of the Oxford classification of IgA nephropathy in children with Henoch-Schonlein purpura nephritis. J Nephrol. 2018;31(2):279–286. doi:10.1007/s40620-017-0457-z PubMed DOI
Barbour SJ Coppo R Er L, et al. . Updating the international IgA nephropathy prediction Tool for use in children. Kidney Int. 2021;99(6):1439–1450. doi:10.1016/j.kint.2020.10.033 PubMed DOI
Trimarchi H Barratt J Cattran DC, et al. . Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int. 2017;91(5):1014–1021. doi:10.1016/j.kint.2017.02.003 PubMed DOI
Wuhl E, Witte K, Soergel M, Mehls O, Schaefer F.; German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens. 2002;20(10):1995–2007. doi:10.1097/00004872-200210000-00019 PubMed DOI
Hogan MC Reich HN Nelson PJ, et al. . The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseases. Kidney Int. 2016;90(5):1080–1089. doi:10.1016/j.kint.2016.06.020 PubMed DOI PMC
Pottel H Hoste L Dubourg L, et al. . An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant. 2016;31(5):798–806. doi:10.1093/ndt/gfv454 PubMed DOI PMC
Gwet KL. Handbook of Inter-rater Reliability: The Definitive Guide to Measuring the Extent of Agreement Among Raters, 4 ed. Advanced Analytics LLC; 2014.
Hallgren KA. Computing inter-rater reliability for observational data: an overview and tutorial. Tutor Quant Methods Psychol. 2012;8(1):23–34. doi:10.20982/tqmp.08.1.p023 PubMed DOI PMC
Dancey CP, Reidy J. Statistics without Maths for Psychology: Using SPSS for Windows, 4 ed. Prentice Hall; 2007.
Herle M Micali N Abdulkadir M, et al. . Identifying typical trajectories in longitudinal data: modelling strategies and interpretations. Eur J Epidemiol. 2020;35(3):205–222. doi:10.1007/s10654-020-00615-6 PubMed DOI PMC
Nguena Nguefack HL Page MG Katz J, et al. . Trajectory modelling techniques useful to epidemiological Research: a comparative narrative review of approaches. Clin Epidemiol. 2020;12:1205–1222. doi:10.2147/CLEP.S265287 PubMed DOI PMC
Boucquemont J Loubere L Metzger M, et al. . Identifying subgroups of renal function trajectories. Nephrol Dial Transplant. 2017;32(suppl 2):ii185–ii193. doi:10.1093/ndt/gfw380 PubMed DOI
Bellur SS Roberts ISD Troyanov S, et al. . Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort. Nephrol Dial Transplant. 2019;34(10):1681–1690. doi:10.1093/ndt/gfy337 PubMed DOI
Koskela M Ylinen E Autio-Harmainen H, et al. . Prediction of renal outcome in Henoch-Schonlein nephritis based on biopsy findings. Pediatr Nephrol. 2020;35(4):659–668. doi:10.1007/s00467-019-04415-3 PubMed DOI PMC
Haas M Verhave JC Liu ZH, et al. . A multicenter study of the predictive value of crescents in IgA nephropathy. J Am Soc Nephrol. 2017;28(2):691–701. doi:10.1681/ASN.2016040433 PubMed DOI PMC
Trimarchi H, Haas M, Coppo R. Crescents and IgA nephropathy: a delicate marriage. J Clin Med. 2022;11(13):3569. doi:10.3390/jcm11133569 PubMed DOI PMC
Peruzzi L, Coppo R. IgA vasculitis nephritis in children and adults: one or different entities? Pediatr Nephrol. 2021;36(9):2615–2625. doi:10.1007/s00467-020-04818-7 PubMed DOI
Kusumoto Y, Takebayashi S, Taguchi T, Harada T, Naito S. Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese. Clin Nephrol. 1987;28(3):118–124. PMID: 3665204 PubMed
Coppo R Andrulli S Amore A, et al. . Predictors of outcome in Henoch-Schonlein nephritis in children and adults. Am J Kidney Dis. 2006;47(6):993–1003. doi:10.1053/j.ajkd.2006.02.178 PubMed DOI
Lv J Wong MG Hladunewich MA, et al. . Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA. 2022;327(19):1888–1898. doi:10.1001/jama.2022.5368 PubMed DOI PMC
Lafayette R Kristensen J Stone A, et al. . Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial. Lancet. 2023;402(10405):859–870. doi:10.1016/S0140-6736(23)01554-4 PubMed DOI
Goldstein AR, White RH, Akuse R, Chantler C. Long-term follow-up of childhood Henoch-Schonlein nephritis. Lancet. 1992;339(8788):280–282. doi:10.1016/0140-6736(92)91341-5 PubMed DOI
Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study. Lancet. 2002;360(9334):666–670. doi:10.1016/S0140-6736(02)09835-5 PubMed DOI